In-Licensing

Ethypharm is one of the leading European speciality pharmaceutical companies.

We have an active partnering strategy to in-licence products or late stage projects which are driving growth and helping us to strengthen our portfolio.

We are strengthening this position and we are expanding nationally and globally. Our Business Development Team is helping us to constantly offer the best products in the areas of Pain, Addiction and Critical Care.

DO YOU HAVE MORE QUESTIONS ON OUR PARTNERSHIPS?

DO YOU HAVE A PROJECT YOU WANT TO DISCUSS WITH US?

Our Business Development Department is always looking at new opportunities and seeks to utilise our in-house capabilities through:
In-licensing
Acquisition of new products
Product development opportunities and collaborations
Global Strategic partnerships and alliances.

PARTNER WITH US!
PLEASE CONTACT information@ethypharm.com FOR MORE INFORMATION ON HOW WE CAN WORK TOGETHER.

By clicking on this link, you agree to leave our website.
Are you sure?

NO YES

FREQUENTLY ASKED QUESTIONS

select products

PRODUCTSREQUESTS

Abtard®

Are there bioequivalence data with OxyContin?
Yes, data from twelve bioequivalence studies comparing Abtard with the reference product were submitted in support of the application for Marketing Authorisation.
How do I store Abtard® tablets?
We do not have information on the stability of Abtard® tablets outside of the original packaging. Abtard® tablets must be stored below 25°C in the original packaging to protect from moisture.
Is Abtard Monophasic or biphasic?
Abtard prolonged -release tablets are bioequivalent to OxyContin prolonged-release tablets and are biphasic, meaning that there is an initial absorption of approximately 40% of oxycodone from the tablet providing onset of analgesia within one hour in most patients, followed by a more controlled absorption, which determines the 12-hour duration or action.
How do I take Abtard® tablets?
Abtard® tablets must be taken as directed by your doctor or pharmacist. Abtard® tablets must be swallowed whole with a sufficient amount of liquid and not chewed.
Are the tablets film coated?
Yes they are
Are 2 x 60mg tablets bioequivalent to a single 120mg strength of OxyContin?
There are no bioequivalence studies for Abtard 2 x 60mg versus one single dose of 120mg of OxyContin. It is a matter of clinical judgement for the prescriber to decide whether 2 x 60 mg tablets can be used. What the bioequivalence studies prove is that Abtard 60mg is bioequivalent to OxyContin 60mg. In practice if a retail pharmacist received a prescription for 120mg of OxyContin and only had the 60mg OxyContin available would they give 2 x 60mg tablets

DIDN'T FIND WHAT YOU WERE LOOKING FOR?
Please feel free to contact us for any further question. Please note that we are unable to provide medical advice.
Contact: medinfo@martindalepharma.co.uk

HOW MUCH COULD YOU SAVE ?

CHOOSE YOUR CCG

TOTAL CCG
SAVINGS across our products

£0.00

CHOOSE A PRACTICE NAME

TOTAL PRACTICE
SAVINGS across our products

£0.00

England & Wales
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in England & Wales by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.

NHS Prescription Services, part of the NHS Business Services Authority (BSA), is the provider of the England data and NHS Wales Shared Partnerships Services is the provider of the Wales data.

This public sector information is licensed under the Open Government Licence v3.0.

The cost model compares Ethypharm products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.

Scotland
The data in this dashboard includes General Practice Prescribing Data - NHS prescriptions that are prescribed in Scotland by GPs, and non medical prescribers that have prescribed on behalf of the GP practice, that are then dispensed in the community.

ISD, NHS Scotland is the provider of the data.

This public sector information is licensed under the Open Government Licence v3.0.

The cost model compares Ethypharm products to alternative products. Only comparable doses of alternative products, which can be clearly identified in the NHS prescription data, are used in the model.